Altaba Inc (NASDAQ:AABA) Position Reduced by Fmr LLC

FMR LLC lowered its stake in shares of Altaba Inc (NASDAQ:AABA) by 25.1% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,896,628 shares of the company’s stock after selling 634,584 shares during the quarter. FMR LLC owned about 0.37% of Altaba worth $140,578,000 at the end of the most recent reporting period.

Other hedge funds also recently made changes to their positions in the company. Mackenzie Financial Corp acquired a new position in shares of Altaba in the fourth quarter valued at approximately $3,178,000. FDx Advisors Inc. acquired a new position in shares of Altaba in the fourth quarter valued at approximately $511,000. PNC Financial Services Group Inc. raised its position in shares of Altaba by 0.7% in the fourth quarter. PNC Financial Services Group Inc. now owns 47,784 shares of the company’s stock valued at $2,769,000 after buying an additional 340 shares during the last quarter. Stratos Wealth Partners LTD. acquired a new position in shares of Altaba in the fourth quarter valued at approximately $397,000. Finally, Doyle Wealth Management acquired a new position in shares of Altaba in the fourth quarter valued at approximately $105,000. 78.62% of the stock is currently owned by institutional investors and hedge funds.

AABA stock traded down $0.08 on Thursday, hitting $70.36. 6,866,900 shares of the company were exchanged, compared to its average volume of 6,864,978. Altaba Inc has a twelve month low of $54.75 and a twelve month high of $79.18. The company has a fifty day simple moving average of $67.14.

A number of research firms have recently weighed in on AABA. Zacks Investment Research raised shares of Investar from a “hold” rating to a “buy” rating and set a $27.00 price objective for the company in a research report on Tuesday, June 4th. ValuEngine lowered shares of Valero Energy from a “hold” rating to a “sell” rating in a research report on Wednesday, May 8th. JPMorgan Chase & Co. cut their price objective on shares of Realogy from $14.00 to $12.00 and set an “underweight” rating for the company in a research report on Thursday, April 4th. Finally, BidaskClub lowered shares of Vertex Pharmaceuticals from a “buy” rating to a “hold” rating in a research report on Tuesday, July 9th. One analyst has rated the stock with a sell rating, three have issued a hold rating and one has issued a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $96.50.

About Altaba

Altaba Inc operates as a non-diversified, closed-end management investment company in the United States. Its assets consist primarily of equity investments, short-term debt investments, and cash. The company was formerly known as Yahoo! Inc and changed its name to Altaba Inc in June 2017. Altaba Inc was founded in 1994 and is based in New York, New York.

See Also: Liquidity

Institutional Ownership by Quarter for Altaba (NASDAQ:AABA)

Receive News & Ratings for Altaba Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Altaba and related companies with MarketBeat.com's FREE daily email newsletter.